menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Bio News

>

Purdue Cen...
source image

Bioengineer

1d

read

45

img
dot

Image Credit: Bioengineer

Purdue Center Launches First Comprehensive Open-Access Database of All Clinically Tested Drugs

  • Purdue University's College of Pharmacy is now home to the Center for Research Innovation in Biotechnology (CRIB) and the Clinical Drug Experience Knowledgebase (CDEK), offering a new paradigm for pharmaceutical research and drug development.
  • The shift of CRIB and CDEK from Washington University to Purdue reflects a commitment to leveraging data analytics and artificial intelligence for advancing drug discovery.
  • CDEK serves as a groundbreaking repository of clinically tested active pharmaceutical ingredients (APIs), integrating vast datasets and computational tools to enhance drug development insights.
  • The collaboration between Purdue and Stony Brook University under CRIB focuses on compiling and analyzing pharmaceutical data across historic approvals, trials, and clinical applications.
  • CDEK's unique integrative approach combines scientific, business, legal, and clinical data, providing researchers with an unparalleled vantage into drug development dynamics.
  • CRIB's initiative corrects data ambiguities by enriching datasets with detailed annotations, enabling nuanced analysis vital for understanding drug efficacy and market dynamics.
  • The CDEK database's extensive temporal coverage spanning over two centuries facilitates the identification of longitudinal trends in drug development, aiding predictive modeling efforts.
  • The integration of CRIB and CDEK at Purdue aligns with the university's efforts to enhance research infrastructure and foster data-driven insights for accelerated biomedical innovation.
  • CDEK's open-access model democratizes API data, catering to diverse user interests including historians, investors, and policymakers beyond the scientific community.
  • Artificial intelligence plays a central role in refining and expanding CDEK, enabling predictive modeling crucial for optimizing clinical trial outcomes and resource allocation in pharmaceutical development.

Read Full Article

like

2 Likes

For uninterrupted reading, download the app